A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...

Clinical trial NCT00923481 · COMPLETED

Trial details

NCT number: NCT00923481
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms Pheochromocytoma Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell

Start date: 2009-04-01
Primary completion: 2009-04-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.